Crossover study of the haematological effects and pharmacokinetics of glycosylated and non-glycosylated G-CSF in healthy volunteers

British Journal of Haematology

Volumn 98, Issue 2, 1997, Pages 474-479

  Watts, M J ^a   Addison, I ^a   Long, S G ^b   Hartley, S ^b   Warrington, S ^c   Boyce, M ^c   Linch, D C ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b Chugai Pharma UK   (United Kingdom)

^c CENTRAL MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

G CSF glycosylation; Mobilization; PBSC; Serum levels

Indexed keywords

PARACETAMOL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AREA UNDER THE CURVE; ARTHRALGIA; ARTICLE; BONE PAIN; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; GLYCOSYLATION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; MALE; NEUTROPHIL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0030844875     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.2393053.x     Document Type: Article

References (24)

1. Cebon, J., Nicola, N., Ward, M., Gardner, I., Dempsey, P., Layton, J., Duhrsen, U., Burgess, A.W., Nice, E. & Morstyn, G. (1990) Granulocyte-macrophage colony stimulating factor from human lymphocytes: the effect of glycosylation on receptor binding and biological activity. Journal of Biological Chemistry, 265, 4483-4491.
2. Decleva, K., Cramer, R. & Zabucchi, G. (1995) Glycosylation improves the priming effect exerted by recombinant human granulocyte colony-stimulating factor (lenograstim) on human neutrophil superoxide production. International Journal of Tissue Reactions, 17, 191-198.
3. Elliott, C., Samson, D.M., Armitage, S., Lyttelton, M.P., McGuigan, D., Hargreaves, R., Giles, C., Abrahamson, G., Abboudi, Z., Brennan, M. & Kanfer, E.J. (1996) When to harvest peripheral-blood stem cells after mobilization therapy: prediction of CD34-positive cell yield by preceding day CD34-positive concentration in peripheral blood. Journal of Clinical Oncology, 14, 970-973.
4. Fukuda, M., Sasaki, H. & Fukuda, M.N. (1989) Erythropoietin metabolism and the influence of carbohydrate structure. Erthropoietin: from Molecular Structure to Clinical Application (ed. by C. A. Baldamus, P. Scigalla, L. Wieczorek and K. M. Koch). pp. 76, 78-89, Karger, Basel.
5. Gianni, A.M., Bregni, M., Siena, S., Orazi, A., Stern, A.C., Gandola, L. & Bonnadonna, G. (1989) Rapid and complete haematological reconstitution following combined transplantation of autologous blood and bone marrow cells: a changing role for high dose chemo-radiotherapy? Hematological Oncology, 7, 139-148.
6. Haas, R., Ehrhardt, R., Witt, B., Goldschmidt, H., Hohaus, S., Pforsich, M., Ehrlich, H., Farber, L. & Hunstein, W. (1993) Autografting with peripheral blood stem cells mobilized by sequential interleukin-3/granulocyte-macrophage colony-stimulating factor following high-dose chemotherapy in non-Hodgkin's lymphoma. Bone Marrow Transplantation, 12, 643-649.
7. + hematopoietic progenitor cells. Blood, 85, 1936-1943.
8. Höglund, M., Bengtsson, M., Cour-Chabernaud, V. Dabouz-Harrouche, F., Simonsson, B., Smedmyr, B. & Tötterman, T. (1995) Glycosylated rHuG-CSF is more potent than non-glycosylated rHuG-CSF in mobilization of peripheral blood progenitor cells (PBPC) in healthy volunteers. Blood, 86, 464a.
9. Jones, H.M., Picozzi, V.J., Price, T.H., Heimfeld, M.A., Eagan, B.L., Fogarty, B.L., Vanderbosch, L.J., Benyunes, M.C., Krieger, M.S. & Tamowski, S.J. (1996) Peripheral blood progenitor harvest following mobilization using G-CSF: experience in collections from 99 normal subjects. Blood, 88, 679a (abstract 2705).
10. Khwaja, A., Carver, J., Jones, H.M. Paterson, D. & Linch, D.C. (1993) Expression and dynamic modulation of the human granulocyte colony-stimulating factor receptor in immature and differentiated myeloid cells. British Journal of Haematology, 85, 254-259.
11. Kiriyama, R., Chichibu, K., Matsuno, T. & Ohsawa, N. (1993) Sensitive chemiluminescent immunoassay for human granulocyte colony-stimulating factor (G-CSF) in clinical applications. Clinica Chimica Acta, 220, 201-209.
12. Kishita, M., Motojima, H., Oh-eda, M., Kojima, T., Kamachi, S., Fukushima, M. & Ono, M. (1992) Stability of granulocyte colony-stimulating factor (G-CSF) in serum. The Clinical Report, 26, 221.
13. Kubota, N., Orita, T., Hattori, K., Oh-eda, M., Ochi, N. & Yamazaki, T. (1990) Stuctural characterization of natural and recombinant human granulocyte colony-stimulating factors. Journal of Biochemistry, 107, 486-492.
14. Metcalf, D. (1990) The colony stimulating factors: discovery, development and clinical applications. Cancer, 65, 2185-2195.
15. Nissen, C., Dalle Carbonare, V. & Moser, Y. (1994) In vitro comparison of the biological potency of glycosylated versus nonglycosylated rG-CSF. Drug Investigation, 7, 346-352.
16. Peters, W.P., Rosner, G., Ross, M., Vredenburgh, J., Meisenberg, B., Gilbert, C. & Kurtzburg, J. (1995) Comparative effects of granulocyte-macrophage colony stimulating factor (GM-CSF) and granulocyte colony stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high dose chemotherapy. Blood, 81, 1709-1719.
17. Pettengell, R., Luft, T., Henschler, R., Hows, J.M., Dexter, T.M., Ryder, D. & Testa, N.G. (1994) Direct comparison by limiting dilution analysis of long-term culture-initiating cells in human bone marrow, umbilical cord blood, and blood stem cells. Blood, 84, 3653-3659.
18. Rapoport, A.P., Abboud, C.N. & Dipersio, J.F. (1992) Granulocytemacrophage colony stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF): receptor biology, signal transduction, and neutrophil activation. Blood Reviews, 6, 43-57.
19. Roberts, A.W., DeLuca, E., Begley, C.G., Basser, R., Grigg, A.P. & Metcalf, D. (1995) Broad inter-individual variation in circulating progenitor cell numbers induced by granulocyte colony stimulating factor therapy. Stem Cells, 13, 512-516.
20. Schmitz, N., Linch, D.C., Dreger, P., Goldstone, A.H., Boogaerts, M.A., Ferrant, A., Demuynck, H.M.S., Link, H., Zander, A., Barge, A. & Borkett, K. (1996) Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet, 347, 353-357.
21. Sheridan, W.P., Begley, C.G., Juttner, C.A., Szer, J., To, L.B., Maher, D., McGrath, K.M., Morstyn, G. & Fox, R.M. (1992) Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet, 339, 640-644.
22. Souza, L.M., Boone, T.C., Gabrilove, J., Lai, P.H., Zsebo, K.M., Murdock, D.C., Chazin, V.R., Bruszewski, J., Lu, H., Chen, K.K., Barendt, J., Platzer, E., Moore, M.A.S., Mertelsmann, R. & Welte, K. (1986) Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. Science, 232, 61-65.
23. Stute, N., Santana, V.M., Rodman, J.H., Schell, M.J. & Ihle, J.N. (1992) Pharmacokinetics of subcutaneous recombinant human granulocyte colony-stimulating factor in children. Blood, 79, 2849-2854.
24. Watts, M.J., Jones, H.M., Sullivan, A.M., Langaheer, S.E., Jamieson, E., Fielding, A., Williams, C., Berenson, R.J., Goldstone, A.H. & Linch, D.C. (1995) Accessory cells do not contribute to G-CSF or IL-6 production nor to rapid haematological recovery following peripheral blood stem cell transplantation. British Journal of Haematology, 91, 767-772.